[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE362912T1 - Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha - Google Patents

Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha

Info

Publication number
ATE362912T1
ATE362912T1 AT00979457T AT00979457T ATE362912T1 AT E362912 T1 ATE362912 T1 AT E362912T1 AT 00979457 T AT00979457 T AT 00979457T AT 00979457 T AT00979457 T AT 00979457T AT E362912 T1 ATE362912 T1 AT E362912T1
Authority
AT
Austria
Prior art keywords
group
alkyl
hydrogen
alkoxycarbonyl
alkylthio
Prior art date
Application number
AT00979457T
Other languages
English (en)
Inventor
Erik Ottosen
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of ATE362912T1 publication Critical patent/ATE362912T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C325/00—Thioaldehydes; Thioketones; Thioquinones; Oxides thereof
    • C07C325/02—Thioketones; Oxides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00979457T 1999-12-06 2000-11-29 Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha ATE362912T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16933399P 1999-12-06 1999-12-06

Publications (1)

Publication Number Publication Date
ATE362912T1 true ATE362912T1 (de) 2007-06-15

Family

ID=22615235

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00979457T ATE362912T1 (de) 1999-12-06 2000-11-29 Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha

Country Status (19)

Country Link
US (1) US6541670B2 (de)
EP (1) EP1237845B1 (de)
JP (1) JP4684515B2 (de)
KR (1) KR20020071876A (de)
CN (1) CN1193003C (de)
AT (1) ATE362912T1 (de)
AU (1) AU776395B2 (de)
BR (1) BR0016164A (de)
CA (1) CA2393312C (de)
CZ (1) CZ20021940A3 (de)
DE (1) DE60034961T2 (de)
ES (1) ES2287040T3 (de)
HK (1) HK1053463A1 (de)
HU (1) HUP0203813A3 (de)
MX (1) MXPA02005604A (de)
NZ (1) NZ519172A (de)
PL (1) PL356049A1 (de)
RU (1) RU2260422C2 (de)
WO (1) WO2001042189A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
JP2002509888A (ja) * 1998-03-27 2002-04-02 オレゴン ヘルス サイエンシーズ ユニバーシティー 腫瘍および他の過増殖性疾患の治療におけるビタミンｄおよびその類似体
AU2001260081B2 (en) 2000-05-22 2005-07-28 Leo Pharma A/S Benzophenones as inhibitors of il-1beta and tnf-alpha
AU2001278956B2 (en) * 2000-07-18 2007-04-05 Genzyme Corporation Stabilized 1alpha-hydroxy vitamin d
EP1313697B1 (de) 2000-08-29 2005-11-30 Nobex Corporation Immunoregulierende verbindungen, deren derivate und ihre verwendung
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
CN100347151C (zh) 2001-08-28 2007-11-07 利奥制药有限公司 新的氨基苯酰苯类化合物
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
CA2492033A1 (en) 2002-07-09 2004-01-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
EP1583735A2 (de) * 2002-12-20 2005-10-12 Leo Pharma A/S Neue aminobenzophenonverbindungen
AU2004259264B2 (en) 2003-07-24 2011-01-06 Leo Pharma A/S Novel aminobenzophenone compounds
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
EP1773767B1 (de) 2004-07-07 2016-03-09 Biocon Limited Synthese von azogebundenen, das immunsystem regulierenden verbindungen
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
CA2590479A1 (en) * 2004-12-13 2006-06-22 Leo Pharma A/S Triazole substituted aminobenzophenone compounds
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP1992344A1 (de) 2007-05-18 2008-11-19 Institut Curie P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind
EP2206534A1 (de) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten
CN102695955B (zh) * 2009-10-26 2015-03-18 雀巢产品技术援助有限公司 检测抗-tnf药物和自身抗体的试验
JP6218229B2 (ja) 2011-12-28 2017-10-25 京都府公立大学法人 角膜内皮細胞の培養正常化
EP3052190A4 (de) 2013-10-01 2017-07-19 New York University Amino-, amido- und heterocyclische verbindungen als modulatoren der wutaktivität und verwendungen davon
US10813920B2 (en) 2013-11-14 2020-10-27 The Doshisha Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57177058A (en) 1981-04-24 1982-10-30 Hodogaya Chem Co Ltd Novel fluoran compound
AU5921890A (en) * 1989-06-13 1991-01-08 Smithkline Beecham Corporation Monokine activity interference
JPH08104817A (ja) * 1994-10-03 1996-04-23 Nippon Soda Co Ltd 新規なフルオラン化合物及びそれを用いた発色性記録材料
GB9701453D0 (en) * 1997-01-24 1997-03-12 Leo Pharm Prod Ltd Aminobenzophenones
KR100572534B1 (ko) * 1997-10-14 2006-04-24 미츠비시 웰파마 가부시키가이샤 피페라진 화합물 및 그 의약으로서의 용도
JPH11217387A (ja) * 1998-01-27 1999-08-10 Yamada Chem Co Ltd フルオラン化合物及びこれを用いた発色性記録材料
US6624199B1 (en) * 1999-07-16 2003-09-23 Leo Pharmaceuticals Products Ltd. A/S Aminobenzophenones

Also Published As

Publication number Publication date
CZ20021940A3 (cs) 2003-01-15
WO2001042189A1 (en) 2001-06-14
JP2003516377A (ja) 2003-05-13
BR0016164A (pt) 2002-08-13
MXPA02005604A (es) 2004-09-10
RU2002118113A (ru) 2004-02-20
EP1237845B1 (de) 2007-05-23
CN1193003C (zh) 2005-03-16
HUP0203813A3 (en) 2008-03-28
RU2260422C2 (ru) 2005-09-20
DE60034961T2 (de) 2008-01-24
HUP0203813A2 (hu) 2003-03-28
CA2393312A1 (en) 2001-06-14
HK1053463A1 (en) 2003-10-24
JP4684515B2 (ja) 2011-05-18
US6541670B2 (en) 2003-04-01
AU1693501A (en) 2001-06-18
DE60034961D1 (de) 2007-07-05
CA2393312C (en) 2011-07-12
AU776395B2 (en) 2004-09-09
CN1413186A (zh) 2003-04-23
NZ519172A (en) 2004-03-26
KR20020071876A (ko) 2002-09-13
US20030013770A1 (en) 2003-01-16
EP1237845A1 (de) 2002-09-11
ES2287040T3 (es) 2007-12-16
PL356049A1 (en) 2004-06-14

Similar Documents

Publication Publication Date Title
ATE362912T1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
ATE277889T1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
UA94571C2 (en) 3-arylamino pyridine derivatives
MY147780A (en) Carboxamide compounds and their use as calpain inhibitors
TW200718686A (en) Pharmaceutical compounds
DE60014404D1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
ATE277897T1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
DK0984938T3 (da) Cyanoguanidiner som celleproliferationsinhibitorer
DK1210325T3 (da) Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa
DK1202954T3 (da) Nye aminobenzophenoner
SE0302756D0 (sv) Novel Compounds
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BG103867A (en) Cyanoguanidines as cell proliferation inhibitors
DK0984936T3 (da) Cyanoguanidiner som celleproliferationsinhibitorer
ATE324368T1 (de) Heteroarylheteroalkylamin derivate und deren verwendung als inhibitoren der stickoxidsynthase
PL369772A1 (en) Compounds that inhibit factor xa activity
SE0202280D0 (sv) Novel compounds
TW200630095A (en) Pharmaceutical compounds
DE60014915D1 (de) Hypoxanthin- und thiohypxanthin-verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties